Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)

Japan flag Japan · Delayed Price · Currency is JPY
121.00
-14.00 (-10.37%)
At close: Mar 6, 2026
Market Cap13.96B +404.5%
Revenue (ttm)21.34M -21.0%
Net Income-676.25M
EPS-10.59
Shares Out115.40M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume9,716,600
Average Volume18,713,080
Open130.00
Previous Close135.00
Day's Range118.00 - 130.00
52-Week Range38.00 - 350.00
Beta1.53
RSI43.85
Earnings DateFeb 13, 2026

About TYO:4596

Kubota Pharmaceutical Holdings Co., Ltd. develops portfolio of drugs and devices worldwide. The company offers eyeMO remote retinal monitoring device patient-based ophthalmology suite, that includes home-based miniature and NASA high-res version optical coherence tomography devices. Its product pipeline comprises emixustat hydrochloride, which is in Phase III clinical stage used for the treatment of stargardt disease, and Phase II clinical stage used for the treatment of proliferative diabetic retinopathy. Kubota Pharmaceutical Holdings Co., Lt... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 19
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4596
Full Company Profile

Financial Performance

In 2025, TYO:4596's revenue was 21.34 million, a decrease of -20.98% compared to the previous year's 27.00 million. Losses were -676.25 million, -49.23% less than in 2024.

Financial Statements